The bronchitis treatment market is expected to grow during the forecast period due to sedentary lifestyle, addiction to cigarette smoke and chemical pollutants, guidelines from the World Health Organization (WHO), rise in morbidity & mortality associated with bronchitis and stringent regulations to pollutant emission control. However, stringent regulatory scenario and patent expiry of key drugs are likely to hamper the growth of the market in the forecast period.
Bronchitis is a respiratory disease that involves inflammation of the bronchi in the lungs. So, bronchitis is basically an inflammation of the lining of bronchial tubes which carry air to and fro the lungs. Some of the common signs and symptoms of bronchitis contain fatigue, cough, chest discomfort, shortness of breath, production of mucus, etc. The primary treatment for acute bronchitis is symptomatic treatment, though, if the symptoms persists, antimicrobial therapy is recommended by the physicians. Mostly antibacterial such as clarithromycin or azithromycin are administered.
1. Boehringer Ingelheim International GmbH
2. Dr. Reddy's Laboratories Ltd.
3. GlaxoSmithKline plc
4. Pfizer Inc.
6. MELINTA THERAPEUTICS, INC.
8. Novartis AG
9. F. Hoffmann-La Roche Ltd.
10. DBV Technologies
The global bronchitis treatment market is segmented on the basis of treatment, class of drugs and end user. Based on treatment the market is classified as drugs and oxygen therapy. On the basis of class of drugs the market is classified as antibiotics, bronchodilators, anti-inflammatory drugs and mucolytics. On the basis of end user the bronchitis treatment market is classified as hospitals, clinics and drug stores.
The report analyzes factors affecting bronchitis treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the bronchitis treatment market in these regions.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global bronchitis treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bronchitis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.